Intra-nasal Dexmedetomidine for Children Undergoing MRI Imaging
Status:
Unknown status
Trial end date:
2020-10-01
Target enrollment:
Participant gender:
Summary
This study aims to assess the use of intranasal dexmedetomidine (IN-dex) as a sole agent in
aiding the successful completion of a MRI scans in children. Dexmedetomidine, a routinely
used anesthetic agent in our institution, has many benefits including sedation with
neuro-protective and respiratory sparing features. We will test its effectiveness in
completing MRI scans in children that would otherwise be given a full general anesthetic.